Germline - Immortality through Totipotency
R. Lehmann, E. Heard, J. Rossant
EMBL Heidelberg, Germany
Saturday 13 October - Tuesday 16 October 2012
Speakers
Keynote Speakers
Angelika Amon, The Koch Institute, Massachusetts Institute of Technology, USA
John Gurdon, Wellcome Trust/Cancer Research UK Gurdon Institute, University of Cambridge, United Kingdom
Azim Surani, Wellcome Trust/Cancer Research UK Gurdon Institute, University of Cambridge, United Kingdom
Confirmed Speakers
Geneviève Almouzni, CNRS Institut Curie, France
María Blasco, Spanish National Cancer Research Centre, Spain
Déborah Bourc’his, INSERM, France
Anne Brunet, Stanford University, USA
Bradley R. Cairns, University of Utah, USA
Rafal Ciosk, Friedrich Miescher Institute for Biomedical Research, Switzerland
Ueli Grossniklaus, University of Zurich, Switzerland
Takashi Hiiragi, EMBL, Germany
Brian K. Kennedy, Buck Institute, USA
Marty M. Matzuk, Baylor College of Medicine, USA
Kim Nasmyth, University of Oxford, United Kingdom
Huck Hui NG, Genome Institute of Singapore, Singapore
David C. Page, Whitehead Institute, Massachusetts Institute of Technology, USA
Katrin Plath, University of California, Los Angeles, USA
Peter W. Reddien, Whitehead Institute, Massachusetts Institute of Technology, USA
Wolf Reik, Babraham Institute, United Kingdom
Mitinori Saitou, Kyoto University, Japan
Hiroshi Sasaki, Kumamoto University, Japan
Melina Schuh, MRC Laboratory of Molecular Biology, United Kingdom
Susan Strome, University of California Santa Cruz, USA
Maria-Elena Torres-Padilla, The Institute of Genetics and Molecular and Cellular Biology, France
Yukiko Yamashita, University of Michigan, USA